AngioDynamics (NASDAQ:ANGO) Issues FY 2025 Earnings Guidance

AngioDynamics (NASDAQ:ANGO – Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided EPS guidance of -0.420–0.380 for the period, compared to the consensus EPS estimate of -0.410. The company issued revenue guidance of $282.0 million-$288.0 million, compared to the consensus revenue estimate of $284.4 million. AngioDynamics also updated its FY25 […]

Leave a Reply

Your email address will not be published.

Previous post RTX (NYSE:RTX) Rating Increased to Hold at Deutsche Bank Aktiengesellschaft
Next post Bank OZK (NASDAQ:OZKAP) Announces Quarterly Dividend of $0.29